サマリー

加齢黄斑変性症の世界市場 2022-2026 年
Technavioは加齢黄斑変性市場を監視しており、2022-2026年の間に93億7000万ドルの成長が見込まれ、予測期間中にCAGR12.6％で加速しています。当レポートでは、加齢黄斑変性症市場の全体分析、市場規模・予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。AMDの高い有病率、AMDの治療薬の承認取得の増加、老年人口の増加などが市場を牽引しています。
加齢黄斑変性市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの加齢黄斑変性症市場は、以下のように区分されています。
タイプ別
- ウェット型AMD
- ドライ型AMD
地域別
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、戦略的提携が今後数年間の加齢黄斑変性症市場の成長を促進する主要な理由の1つであると特定しています。また、AMDの遺伝子治療の開発とAMDに関する認知度の向上が、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。加齢黄斑変性症市場に関する当レポートの対象領域は以下の通りです。
- 加齢黄斑変性症市場のサイジング
- 加齢黄斑変性症市場予測
- 加齢黄斑変性症市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Alimera Sciences Inc.、Alkeus Pharmaceuticals Inc.を含むいくつかの加齢黄斑変性市場の主要ベンダーについて詳細な分析を行っています。Allegro Ophthalmics LLC、Amgen Inc、Apellis Pharmaceuticals Inc、Bausch Health Co Inc、Bayer AG、F. Hoffmann La Roche Ltd、Formycon AG、Intas Pharmaceuticals Ltd、Novartis AG、Outlook Therapeutics Inc、Regenon Pharmaceuticals Inc、Reliance Industries Ltd.、Santen Pharmaceutical Co.Ltd.、Xbrane Biopharma ABが含まれています。また、加齢黄斑変性症市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/age-related-macular-degeneration-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Wet AMD - Market size and forecast 2021-2026
o Exhibit 28: Chart on Wet AMD - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Wet AMD - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Wet AMD - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Wet AMD - Year-over-year growth 2021-2026 (%)
o 5.4 Dry AMD - Market size and forecast 2021-2026
o Exhibit 32: Chart on Dry AMD - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Dry AMD - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Dry AMD - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Dry AMD - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Alkeus Pharmaceuticals Inc.
o Exhibit 85: Alkeus Pharmaceuticals Inc. - Overview
o Exhibit 86: Alkeus Pharmaceuticals Inc. - Product / Service
o Exhibit 87: Alkeus Pharmaceuticals Inc. - Key offerings
o 10.4 Allegro Ophthalmics LLC
o Exhibit 88: Allegro Ophthalmics LLC - Overview
o Exhibit 89: Allegro Ophthalmics LLC - Product / Service
o Exhibit 90: Allegro Ophthalmics LLC - Key offerings
o 10.5 Amgen Inc.
o Exhibit 91: Amgen Inc. - Overview
o Exhibit 92: Amgen Inc. - Product / Service
o Exhibit 93: Amgen Inc. - Key offerings
o 10.6 Apellis Pharmaceuticals Inc.
o Exhibit 94: Apellis Pharmaceuticals Inc. - Overview
o Exhibit 95: Apellis Pharmaceuticals Inc. - Product / Service
o Exhibit 96: Apellis Pharmaceuticals Inc. - Key offerings
o 10.7 Bayer AG
o Exhibit 97: Bayer AG - Overview
o Exhibit 98: Bayer AG - Business segments
o Exhibit 99: Bayer AG - Key offerings
o Exhibit 100: Bayer AG - Segment focus
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 101: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 102: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 103: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 104: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 105: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 Formycon AG
o Exhibit 106: Formycon AG - Overview
o Exhibit 107: Formycon AG - Key offerings
o 10.10 Novartis AG
o Exhibit 108: Novartis AG - Overview
o Exhibit 109: Novartis AG - Business segments
o Exhibit 110: Novartis AG - Key offerings
o Exhibit 111: Novartis AG - Segment focus
o 10.11 Outlook Therapeutics Inc.
o Exhibit 112: Outlook Therapeutics Inc. - Overview
o Exhibit 113: Outlook Therapeutics Inc. - Product / Service
o Exhibit 114: Outlook Therapeutics Inc. - Key offerings
o 10.12 Reliance Industries Ltd.
o Exhibit 115: Reliance Industries Ltd. - Overview
o Exhibit 116: Reliance Industries Ltd. - Business segments
o Exhibit 117: Reliance Industries Ltd. - Key offerings
o Exhibit 118: Reliance Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 119: Inclusions checklist
o Exhibit 120: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 121: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 122: Research methodology
o Exhibit 123: Validation techniques employed for market sizing
o Exhibit 124: Information sources
o 11.5 List of abbreviations
o Exhibit 125: List of abbreviations


Exhibits:
Exhibits1: Key Finding 1
Exhibits2: Key Finding 2
Exhibits3: Key Finding 3
Exhibits4: Key Finding 5
Exhibits5: Key Finding 6
Exhibits6: Key Finding 7
Exhibits7: Key Finding 8
Exhibits8: Parent market
Exhibits9: Market characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%)
Exhibits14: Five forces analysis 2020 & 2025
Exhibits15: Bargaining power of buyers
Exhibits16: Bargaining power of suppliers
Exhibits17: Threat of new entrants
Exhibits18: Threat of substitutes
Exhibits19: Threat of rivalry
Exhibits20: Market condition - Five forces 2020
Exhibits21: Type - Market share 2020-2025 (%)
Exhibits22: Comparison by Type
Exhibits23: Wet AMD - Market size and forecast 2020-2025 ($ million)
Exhibits24: Wet AMD - Year-over-year growth 2020-2025 (%)
Exhibits25: Dry AMD - Market size and forecast 2020-2025 ($ million)
Exhibits26: Dry AMD - Year-over-year growth 2020-2025 (%)
Exhibits27: Market opportunity by Type
Exhibits28: Customer landscape
Exhibits29: Market share By Geographical Landscape 2020-2025 (%)
Exhibits30: Geographic comparison
Exhibits31: North America - Market size and forecast 2020-2025 ($ million)
Exhibits32: North America - Year-over-year growth 2020-2025 (%)
Exhibits33: Europe - Market size and forecast 2020-2025 ($ million)
Exhibits34: Europe - Year-over-year growth 2020-2025 (%)
Exhibits35: Asia - Market size and forecast 2020-2025 ($ million)
Exhibits36: Asia - Year-over-year growth 2020-2025 (%)
Exhibits37: ROW - Market size and forecast 2020-2025 ($ million)
Exhibits38: ROW - Year-over-year growth 2020-2025 (%)
Exhibits39: Key leading countries
Exhibits40: Market opportunity By Geographical Landscape ($ million)
Exhibits41: Impact of drivers and challenges
Exhibits42: Vendor landscape
Exhibits43: Landscape disruption
Exhibits44: Industry risks
Exhibits45: Vendors covered
Exhibits46: Market positioning of vendors
Exhibits47: AbbVie Inc. - Overview
Exhibits48: AbbVie Inc. - Product and service
Exhibits49: AbbVie Inc. - Key offerings
Exhibits50: AbbVie Inc. - Key customers
Exhibits51: AbbVie Inc. - Segment focus
Exhibits52: Alkeus Pharmaceuticals Inc. - Overview
Exhibits53: Alkeus Pharmaceuticals Inc. - Product and service
Exhibits54: Alkeus Pharmaceuticals Inc. - Key offerings
Exhibits55: Alkeus Pharmaceuticals Inc. - Key customers
Exhibits56: Alkeus Pharmaceuticals Inc. - Segment focus
Exhibits57: Amgen Inc. - Overview
Exhibits58: Amgen Inc. - Business segments
Exhibits59: Amgen Inc. - Key offerings
Exhibits60: Amgen Inc. - Key customers
Exhibits61: Amgen Inc. - Segment focus
Exhibits62: Bausch Health Companies Inc. - Overview
Exhibits63: Bausch Health Companies Inc. - Business segments
Exhibits64: Bausch Health Companies Inc. - Key offerings
Exhibits65: Bausch Health Companies Inc. - Key customers
Exhibits66: Bausch Health Companies Inc. - Segment focus
Exhibits67: Bayer AG - Overview
Exhibits68: Bayer AG - Business segments
Exhibits69: Bayer AG - Key offerings
Exhibits70: Bayer AG - Key customers
Exhibits71: Bayer AG - Segment focus
Exhibits72: F. Hoffmann-La Roche Ltd. - Overview
Exhibits73: F. Hoffmann-La Roche Ltd. - Business segments
Exhibits74: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibits75: F. Hoffmann-La Roche Ltd. - Key customers
Exhibits76: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibits77: Lupin Ltd. - Overview
Exhibits78: Lupin Ltd. - Product and service
Exhibits79: Lupin Ltd. - Key offerings
Exhibits80: Lupin Ltd. - Key customers
Exhibits81: Lupin Ltd. - Segment focus
Exhibits82: Novartis AG - Overview
Exhibits83: Novartis AG - Business segments
Exhibits84: Novartis AG - Key offerings
Exhibits85: Novartis AG - Key customers
Exhibits86: Novartis AG - Segment focus
Exhibits87: Pfizer Inc. - Overview
Exhibits88: Pfizer Inc. - Business segments
Exhibits89: Pfizer Inc. - Key offerings
Exhibits90: Pfizer Inc. - Key customers
Exhibits91: Pfizer Inc. - Segment focus
Exhibits92: Regeneron Pharmaceuticals Inc. - Overview
Exhibits93: Regeneron Pharmaceuticals Inc. - Product and service
Exhibits94: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits95: Regeneron Pharmaceuticals Inc. - Key customers
Exhibits96: Regeneron Pharmaceuticals Inc. - Segment focus
Exhibits97: Currency conversion rates for US$
Exhibits98: Research Methodology
Exhibits99: Validation techniques employed for market sizing
Exhibits100: Information sources
Exhibits101: List of abbreviations